Literature DB >> 11186980

Methodological advances in cardiac 31P-MR spectroscopy.

M von Kienlin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186980     DOI： 10.1016/s1352-8661(00)00106-x

Source DB:  PubMed          Journal:  MAGMA        ISSN： 0968-5243            Impact factor:   2.533


× No keyword cloud information.
  16 in total

1.  Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease.

Authors:  R G Weiss; P A Bottomley; C J Hardy; G Gerstenblith
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

Review 2.  Human cardiac spectroscopy.

Authors:  P A Bottomley; R G Weiss
Journal:  MAGMA       Date:  1998-09       Impact factor: 2.310

3.  What is the optimum phased array coil design for cardiac and torso magnetic resonance?

Authors:  P A Bottomley; C H Lugo Olivieri; R Giaquinto
Journal:  Magn Reson Med       Date:  1997-04       Impact factor: 4.668

4.  Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy.

Authors:  P A Bottomley; R J Herfkens; L S Smith; T M Bashore
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

5.  Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart.

Authors:  S Schaefer; J Gober; M Valenza; G S Karczmar; G B Matson; S A Camacho; E H Botvinick; B Massie; M W Weiner
Journal:  J Am Coll Cardiol       Date:  1988-12       Impact factor: 24.094

6.  Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy.

Authors:  M Meininger; W Landschütz; M Beer; T Seyfarth; M Horn; T Pabst; A Haase; D Hahn; S Neubauer; M von Kienlin
Journal:  Magn Reson Med       Date:  1999-04       Impact factor: 4.668

7.  31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.

Authors:  S Neubauer; T Krahe; R Schindler; M Horn; H Hillenbrand; C Entzeroth; H Mader; E P Kromer; G A Riegger; K Lackner
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

8.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.

Authors:  C J Hardy; R G Weiss; P A Bottomley; G Gerstenblith
Journal:  Am Heart J       Date:  1991-09       Impact factor: 4.749

9.  Localized spectroscopy from anatomically matched compartments: improved sensitivity and localization for cardiac 31P MRS in humans.

Authors:  R Löffler; R Sauter; H Kolem; A Haase; M von Kienlin
Journal:  J Magn Reson       Date:  1998-10       Impact factor: 2.229

10.  Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy.

Authors:  T Yabe; K Mitsunami; T Inubushi; M Kinoshita
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690
View more
  1 in total

1.  Clinical applications for cardiovascular magnetic resonance imaging at 3 tesla.

Authors:  Allison G Hays; Michael Schär; Sebastian Kelle
Journal:  Curr Cardiol Rev       Date:  2009-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.